These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37560385)

  • 21. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
    Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
    Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TTN mutations predict a poor prognosis in patients with thyroid cancer.
    Han X; Chen J; Wang J; Xu J; Liu Y
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma.
    Wang Q; Liu J; Cheang I; Li J; Chen T; Li Y; Yu B
    Int J Gen Med; 2022; 15():5973-5984. PubMed ID: 35811776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients.
    Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H
    Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Role of Mitochondrial Transcription Termination Factor 3 in Thyroid Carcinoma.
    Sun MT; Zhao HY; Ruan HJ; Yu LH; Guan ML; Fan JJ; Feng CZ; Lou YY
    Genet Test Mol Biomarkers; 2023 Dec; 27(12):362-369. PubMed ID: 38156906
    [No Abstract]   [Full Text] [Related]  

  • 26. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
    Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
    J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
    Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
    Front Genet; 2021; 12():744304. PubMed ID: 34976004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma.
    Shi Y; Sheng P; Guo M; Chen K; Zhou H; Wu M; Li W; Li B
    Front Genet; 2023; 14():1100909. PubMed ID: 37470034
    [No Abstract]   [Full Text] [Related]  

  • 29. DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy.
    Gao X; Le Y; Geng C; Jiang Z; Zhao G; Zhang P
    Int J Endocrinol; 2022; 2022():5181386. PubMed ID: 36467461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bioinformatics analysis for diagnostic roles of the
    Li J; Wang H; Cao F; Cheng Y
    J Gastrointest Oncol; 2022 Oct; 13(5):2115-2131. PubMed ID: 36388667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
    Fei H; Han X; Wang Y; Li S
    Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.
    Liao P; Han S; Qu H
    Biomed Res Int; 2020; 2020():6281635. PubMed ID: 33381564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma.
    Wu P; Shi J; Sun W; Zhang H
    Bioengineered; 2021 Dec; 12(2):12854-12866. PubMed ID: 34898340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration.
    Wu L; Zhou Y; Guan Y; Xiao R; Cai J; Chen W; Zheng M; Sun K; Chen C; Huang G; Zhang X; Qian Z; Shen S
    Front Oncol; 2021; 11():756246. PubMed ID: 35141140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
    Zhang S; Yu S; Wang J; Cheng Z
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33687056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network.
    Luo Y; Ye Y; Zhang Y; Chen L; Qu X; Yi N; Ran J; Chen Y
    Transl Cancer Res; 2023 Dec; 12(12):3384-3408. PubMed ID: 38197076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F, HSF2, and miR-26 in thyroid carcinoma: bioinformatic analysis of RNA-sequencing data.
    Lu JC; Zhang YP
    Genet Mol Res; 2016 Mar; 15(1):15017576. PubMed ID: 26985959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAPN8 involves with exhausted, inflamed, and desert immune microenvironment to influence the metastasis of thyroid cancer.
    Zhong X; Xu S; Wang Q; Peng L; Wang F; He T; Liu C; Ni S; He Z
    Front Immunol; 2022; 13():1013049. PubMed ID: 36389799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer.
    Ren X; Du H; Cheng W; Wang Y; Xu Y; Yan S; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():997873. PubMed ID: 36407322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-omics analysis of the oncogenic role of optic
    Wu Z; Xu N; Li G; Yang W; Zhang C; Zhong H; Wu G; Chen F; Li D
    Aging (Albany NY); 2023 Nov; 15(22):12982-12997. PubMed ID: 37980164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.